Neck & Décolleté Rejuvenation: The 3-Layer Protocol

The most effective approach to neck and décolleté rejuvenation combines three sequential injectable layers: a mesotherapy foundation for cellular repair, a Skin Booster for extracellular matrix hydration, and a biostimulator to drive structural collagen and elastin remodelling. Each layer addresses a distinct biological deficit, and the sequence is the mechanism — compress it and the compounding outcome is lost. A protocol initiated in May–June delivers peak results during July–September, when the décolleté is most exposed and improvements are most visible.

Why the Décolleté Responds Differently to Injectables

The neck and décolleté are not an extension of the face. They constitute a distinct anatomical territory with a different structural profile, a different photoprotection history, and a faster ageing trajectory.

Anatomical profile: The décolletage dermis is thinner than most facial zones, carries significantly lower sebaceous gland density, and supports far fewer pilosebaceous units. The study protocol for NCT05163353 — a prospective multicentre randomised trial evaluating diluted CaHA for décolleté rejuvenation — documents that the chest has over 13 times fewer hair follicles than the lateral forehead. ¹ This structural difference directly affects product spread, injection depth, healing capacity, and overinjection risk in thin tissue. ¹

Reduced sebaceous activity impairs lipid barrier function and accelerates transepidermal water loss. Combined with decades of cumulative UV exposure that most patients never protected with SPF — unlike the face, which benefits from incidental photoprotection — the result is advanced extracellular matrix degradation: fragmented collagen architecture, disorganised elastin, and reduced fibroblast synthetic capacity that manifests years before comparable facial changes. ¹ In female patients, hormonal changes associated with menopause further accelerate this process through oestrogen-driven collagen loss and skin thinning. ¹

In practice, this is why the décolleté underperforms with isolated hydration treatments and overreacts to volumising strategies designed for facial tissue. The biological deficit here is deeper than surface dryness — and the treatment approach must match that.

Layer 01 — Mesotherapy: Cellular Foundation Before Remodelling Begins

What mesotherapy is in this context

Mesotherapy refers to the intradermal delivery of multi-ingredient formulations — vitamins, amino acids, minerals, coenzymes, and hyaluronic acid in combination — designed to replenish cellular raw materials and restore dermal metabolic function. It is not a volumiser and not a biostimulator. Its role in this protocol is preparatory: saturating depleted tissue with the substrates fibroblasts need before any remodelling stimulus is introduced.

Timing

2–3 sessions, 2–3 weeks apart, administered intradermally across the full treatment field.

The strongest published clinical evidence for this zone belongs to NCTF 135HA . The HEBE2 study — a randomised, active-controlled, multicentre trial across 10 centres with 146 subjects — evaluated NCTF 135HA injections specifically across the face, neck, and décolleté. ² At Day 75 and Day 120, NCTF 135HA significantly reduced wrinkles in all three areas and improved skin radiance scores compared with the active cream control group. ² Skin hydration increased significantly seven days after the final injection session, with adverse events predominantly mild and injection-related. ² It remains the only well-powered published RCT evaluating a mesotherapy product specifically on the neck and décolleté.

Not every patient presents with the same Layer 01 indication.

Where photoageing and oxidative damage dominate — visible dyspigmentation, compromised barrier, advanced texture change — Cytocare 532 adds a meaningful antioxidant payload: non-cross-linked HA combined with 20 amino acids and antioxidant co-factors formulated for photodamaged tissue.

Where fibroblast synthetic capacity is the primary deficit, Jalupro HMW provides the amino acid precursors collagen synthesis requires — glycine, L-proline, L-leucine, L-lysine — combined with high molecular weight HA, with approved indications specifically including neck, décolleté, and hands. This amino acid substrate creates a mechanistic continuum with Layer 03: the fibroblasts primed here are the same cells subsequently activated by biostimulation. For a full reference of injectable mesotherapy protocols for this zone , including concentration and session guidance, see the product range.

Layer 02 — Skin Boosters: Restoring the Dermal Hydration Reservoir

What a Skin Booster is — and is not

A Skin Booster is a low or non-cross-linked hyaluronic acid injectable designed to restore the water-binding capacity of the extracellular matrix, improving dermal hydration, suppleness, and skin quality at a tissue level. A Skin Booster does not volumise. The distinction from a dermal filler is categorical — different cross-linking degree, different rheological properties, different biological objective.

Timing

1–2 sessions, 4 weeks after the final Layer 01 session. Can be introduced as a split-protocol alongside Layer 01 in appropriate patient profiles.

A well-hydrated dermal environment is not incidental to protocol outcome — it is structural. Restoring ECM water-binding capacity before biostimulation begins creates the tissue conditions in which Layer 03 products act more effectively and produce longer-lasting results. Biostimulation delivered into dehydrated dermis is less efficient. This is the functional argument for Layer 02, not an optional add-on.

Ejal 40 — 40 mg/ml non-cross-linked high molecular weight HA — is the first-line choice for patients with significant hydration deficit, mature or photodamaged skin, or pronounced crepey texture on the décolleté. The high HA concentration rapidly restores dermal water content.

Refine+ Ultra Soft , at 20 mg/ml cross-linked HA with a low rheological profile, is the right choice where even tissue distribution and minimised overinjection risk are primary clinical considerations — a deliberate specification for thin, reactive anatomy, not a performance compromise. Practitioners building décolleté-specific programmes will find the full selection of Skin Boosters for décolleté hydration available by concentration and molecular weight profile.

Layer 03 — Biostimulation: Driving the Structural Remodelling Cascade

What biostimulation is

A biostimulator is an injectable that stimulates endogenous collagen and/or elastin production through fibroblast activation or scaffold-mediated tissue response. Results are progressive — peak collagen remodelling typically occurs 3–6 months from the first session. This is mechanistically distinct from the immediate hydration a Skin Booster provides, and the two are not interchangeable.

Timing

Begin minimum 2–4 weeks after the final Layer 01 session. Two sessions, 4 weeks apart.

Sunekos 200 combines low molecular weight HA with a patented six amino acid formula — glycine, L-proline, L-hydroxyproline, L-leucine, L-lysine, L-valine — designed to stimulate fibroblast synthesis of both collagen and elastin. ³ The dual induction matters here. Elastin degradation drives the laxity and crepiness characteristic of décolleté photoageing, and it is underaddressed by most biostimulators. Its amino acid substrate is also mechanistically continuous with the Jalupro HMW priming in Layer 01 — the same fibroblasts, now stimulated rather than nourished.

Radiesse (+) 1.5ml administered hyperdiluted operates via a structurally different mechanism. Calcium hydroxylapatite microspheres act as a biostimulatory scaffold, triggering fibroblast proliferation, neocollagenesis, neoelastinogenesis, and angiogenesis as the CaHA degrades. ^4,5 In a prospective clinical trial evaluating hyperdiluted CaHA specifically for chest rejuvenation — 20 subjects, 1:2 dilution, 1-year follow-up — subjects achieved statistically significant improvements in Merz Décolleté Scale scores from a single treatment, with durable results maintained at Day 360. ⁴ The global consensus guidelines published by Goldie et al. in Dermatologic Surgery formalised injection protocols for diluted and hyperdiluted CaHA across face, neck, and body regions. ⁵

Sunekos 200 and hyperdiluted Radiesse (+) are not interchangeable. They are complementary. Different mechanisms in the same tissue can produce additive structural outcomes. ⁵

StiCol Volume — a PLLA and HA hybrid — is indicated where structural deficit exceeds a standard biostimulation course, or where treatment frequency must be minimised. PLLA triggers a controlled foreign body response that drives sustained collagen neogenesis over months, ⁶ with published evidence specific to décolleté application by Wilkerson and Goldberg. ⁷ The HA component provides immediate hydration support during the induction phase. Duration: up to 24 months. The complete reference of biostimulators for structural remodelling , including mechanism comparisons and session guidance, is available in the product range.

Matching the Protocol to the Patient

Two clinical entry points, determined by the degree of structural deficit at presentation:

Presentation	Protocol	Products
Mild–moderate photodamage, early laxity	Layers 01 + 02	NCTF 135HA or Jalupro HMW + Ejal 40 or Refine+ Ultra Soft
Visible laxity, structural thinning, collagen deficit	Layers 01 + 02 + 03	Above + Sunekos 200 or hyperdiluted Radiesse (+)
Significant structural deficit or low treatment frequency	Layers 01 + 02 + 03 (StiCol)	Above with StiCol Volume as Layer 03

In practice, most practitioners build these protocols by selecting a single Layer 01 foundation based on the predominant tissue deficit — oxidative damage, amino acid depletion, or general cellular fatigue — then following with either a hydration-focused pathway (Layers 01 + 02) or a full structural remodelling pathway (Layers 01 + 02 + 03) depending on the degree of laxity and collagen loss present at consultation. The Foundation + Hydration entry is the right starting position for the majority of patients: it establishes tissue quality before any remodelling stimulus is introduced and carries a lower procedural risk profile in thin or reactive skin.

Seasonal Treatment Timeline

Biostimulation results are not immediate — they require 3–6 months from initiation to reach peak collagen remodelling output. Starting now aligns that peak with the July–September window, when the décolleté is most exposed and outcomes are most visible.

Timing	Layer	Sessions
May–June	Layer 01 — Mesotherapy foundation	2–3 sessions, 2–3 weeks apart
June	Layer 02 — Skin Booster	1–2 sessions, 4 weeks after final Layer 01
June–July	Layer 03 — Biostimulation	2 sessions, 4 weeks apart
July–September	Peak improvement window	—

This timeline fits patients presenting now with post-winter photodamage, menopausal skin changes, or the tissue quality and laxity changes increasingly seen in patients undergoing GLP-1-related body composition shifts — a profile where the full three-layer protocol is typically indicated.

Nefertiti Lift: The Neuromodulator Complement

For patients already receiving this injectable protocol, the logical BTX-A addition is the Nefertiti Lift, first described by Levy in Journal of Cosmetic and Laser Therapy in 2007. ⁸ The technique delivers botulinum toxin type A along the inferior mandible and into the platysmal bands, softening vertical neck bands and restoring mandibular definition without surgery. ⁸ Best outcomes are documented in patients with platysmal hyperactivity and retained skin elasticity — a profile that overlaps substantially with the injectable protocol population. ⁸

One practical note: the tissue quality improvements produced by Layers 01–03 create a better-hydrated, more structurally intact dermal environment. Clinical observation suggests this extends the visible duration of the toxin effect — which means the injectable protocol work and the BTX-A work are not independent of each other. They reinforce each other.

Key Takeaways

• The décolleté dermis is thinner than most facial zones, with over 13× fewer pilosebaceous units than the lateral forehead ¹ and greater accumulated UV damage — requiring protocol logic calibrated specifically to this anatomy, not adapted from facial protocols.
• A three-layer sequence addresses cellular nutrition, hydration, and structural remodelling as distinct biological objectives in the correct order. Compressing the sequence compromises the compounding outcome.
• NCTF 135HA is the only mesotherapy product with published RCT data specifically on the neck and décolleté (Fanian et al., HEBE2, J Dermatol Treat , 2023). ² Hyperdiluted Radiesse (+) has prospective clinical trial data specific to chest rejuvenation (PMID 33938688). ⁴
• PLLA’s collagen-stimulating mechanism is well-established across the literature, ⁶ with published data specific to décolleté photodamage by Wilkerson and Goldberg. ⁷
• Biostimulation started now peaks in July–September — the highest-exposure window for this zone.
• Two patient entry points: Layers 01 + 02 for mild-to-moderate presentations; full three-layer remodelling for visible laxity, structural thinning, or deeper collagen deficit.

References

1. NCT05163353. Evaluation of the Effectiveness and Safety of Diluted RADIESSE® in the Treatment of Décolleté Wrinkles. ClinicalTrials.gov. clinicaltrials.gov/study/NCT05163353
2. Fanian F et al. A hyaluronic acid-based micro-filler improves superficial wrinkles and skin quality: a randomized prospective controlled multicenter study (HEBE2). J Dermatol Treat. 2023;34(1):2216323. DOI: 10.1080/09546634.2023.2216323
3. Sacchi P, Rauso R. Clinical Trial for Assessing the Effectiveness and Tolerability of the Medical Device Sunekos 200, Applied with Electroporator in Skin Ageing. Clin Dermatol J. 2018;3(2):000152. medwinpublishers.com/CDOAJ/CDOAJ16000152.pdf
4. Mazzuco R et al. Prospective Clinical Trial Evaluating the Long-Term Safety and Efficacy of Calcium Hydroxylapatite for Chest Rejuvenation. J Drugs Dermatol. 2021;20(5). PMID: 33938688. DOI: 10.36849/JDD.5680
5. Goldie K, Peeters W, Alghoul M et al. Global Consensus Guidelines for the Injection of Diluted and Hyperdiluted Calcium Hydroxylapatite for Skin Tightening. Dermatol Surg. 2018;44(Suppl 1):S32–S41. PMID: 30358631. DOI: 10.1097/DSS.0000000000001685
6. Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg. 2006;118(3 Suppl):46S–54S. PMID: 16936520. DOI: 10.1097/01.prs.0000234846.00628.78
7. Wilkerson EC, Goldberg DJ. Poly-L-lactic acid for the improvement of photodamage and rhytids of the décolletage. J Cosmet Dermatol. 2018;17(4):606–610. DOI: 10.1111/jocd.12447
8. Levy PM. The ‘Nefertiti lift’: a new technique for specific re-contouring of the jawline. J Cosmet Laser Ther. 2007;9(4):249–252. PMID: 18236245. DOI: 10.1080/14764170701545657

Neck & Décolleté Rejuvenation

Why is the décolleté structurally more challenging to treat than the face?

The chest has over 13 times fewer hair follicles than the lateral forehead, with a thinner dermis and lower sebaceous gland density — all of which impair barrier function, slow healing, and increase overinjection risk.¹ Combined with a lifetime of unprotected UV exposure, the ECM deficit in this zone typically precedes comparable facial changes by years.

Why must the three layers follow a sequence rather than run simultaneously?

Each layer prepares the tissue for what follows. Mesotherapy replenishes the cellular raw materials depleted fibroblasts need to respond;² Skin Boosters restore ECM hydration before any remodelling stimulus is applied. Biostimulation delivered into poorly nourished, dehydrated dermis underperforms relative to prepared tissue. The sequence is the mechanism, not a scheduling preference.

What distinguishes Sunekos 200 from hyperdiluted Radiesse (+) in this zone?

Different mechanisms: Sunekos 200 stimulates fibroblasts directly via its HA and amino acid formula, inducing both collagen and elastin.³ Hyperdiluted Radiesse (+) acts as a CaHA scaffold, triggering neocollagenesis, neoelastinogenesis, and angiogenesis as the microspheres degrade.⁴ʼ⁵ They are complementary — not interchangeable — and can produce additive outcomes when used together.

Which patients should be considered for StiCol Volume rather than standard biostimulators?

StiCol Volume is best suited to patients where structural deficit is more advanced than a standard two-session course can address, where visit frequency is a practical constraint, or where a 24-month outcome duration is the clinical priority.⁶ʼ⁷ Standard biostimulators remain first-line for patients with adequate collagen synthesis capacity and normal compliance.

Is this protocol applicable to patients on GLP-1 medications?

Yes. GLP-1-related weight loss can accelerate laxity and ECM degradation in the décolleté zone in ways that parallel accelerated photoageing.¹ The layered protocol addresses these consequences directly across all three layers.²ʼ³ʼ⁴ For this profile, the full three-layer protocol is typically indicated, with PLLA-based options offering particular relevance where long-term structural support is the priority.